12:00 AM
Sep 29, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Seasonal influenza VLP vaccine: Phase IIa completed

Novavax completed enrollment of about 300 healthy volunteers in a double-blind, placebo-controlled, U.S. Phase lla trial evaluating a single IM injection of 5, 15 or 30 µg of...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >